1,1-环丁基二羧酸二甲酯 | 10224-72-3

• 物质功能分类: 有机原料 - 羧酸类化合物及衍生物
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 中文名称: 1,1-环丁基二羧酸二甲酯
• 中文别名: 环丁基-1,1-二羧酸二甲酯；二甲基环丁烷-1,1-二羧酸；1,1-环丁烷-乙二酸酯
• 英文名称: cyclobutane-1,1-dicarboxylic acid dimethyl ester
• 英文别名: Dimethyl cyclobutane-1,1-dicarboxylate
• CAS: 10224-72-3
• 化学式: C₈H₁₂O₄
• 分子量: 172.181
• InChiKey: KIFHUHBBUBVJNH-UHFFFAOYSA-N

物化性质

• 沸点：
  122°C 55mm
• 密度：
  1,118 g/cm3
• 闪点：
  122°C/55mm
• 稳定性/保质期：
  遵照规格使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  52.6
• 氢给体数：
  0
• 氢受体数：
  4

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S23,S24/25
• 储存条件：
  请将密封于阴凉干燥处。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: Dimethyl cyclobutane-1,1-dicarboxylate
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: Dimethyl cyclobutane-1,1-dicarboxylate
CAS number: 10224-72-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C8H12O4
Molecular weight: 172.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1,1-环丁基二羧酸二甲酯 以 四氢呋喃 为溶剂， 生成 1-(hydroxymethyl)cyclobutane-1-carboxylic acid methyl ester
  参考文献：
  名称：

  具有AKT激酶抑制活性的杂环化合物及其制备方法和医药用途

  摘要：

  本发明涉及具有AKT激酶抑制活性的杂环化合物及其制备方法和医药用途。具体地，本发明涉及通式(I)所示的化合物，其制备方法，含有其的药物组合物，以及其作为AKT激酶抑制剂在预防和/或治疗异常细胞生长如癌症的药物中的用途。通式(I)中的各基团的定义与说明书中的定义相同。

  公开号：

  CN116514817A
• 作为产物：
  描述：

  1,1-环丁基二甲酸 在 硫酸 、 苯 作用下， 生成 1,1-环丁基二羧酸二甲酯
  参考文献：
  名称：

  364.物理性质和化学组成。第十八部分。三元和四元碳环

  摘要：

  DOI：

  10.1039/jr9480001804

文献信息

• [EN] BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS<br/>[FR] COMPOSÉS BICYCLIQUES SUBSTITUÉS PAR HÉTÉROARYLE
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2018013774A1

  公开（公告）日：2018-01-18

  Disclosed are compounds of Formula (I) to (VIII): (I) (II) (III) (IV) (V) (VI) (VII) (VIII); or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate or prodrug thereof, wherein R3 is a bicyclic heteroaryl group substituted with zero to 3 R3a; and R1, R2, R3a, R4, and n are defined herein. Also disclosed are methods of using such compounds as PAR4 inhibitors, and pharmaceutical compositions comprising such compounds. These compounds are useful in inhibiting or preventing platelet aggregation, and are useful for the treatment of a thromboembolic disorder or the primary prophylaxis of a thromboembolic disorder.

  公开了公式(I)至(VIII)的化合物：(I) (II) (III) (IV) (V) (VI) (VII) (VIII)；或其立体异构体、互变异构体、药物可接受的盐、溶剂化物或前药，其中R3是与0至3个R3a取代的双环杂芳基团；且R1、R2、R3a、R4和n在此定义。还公开了使用这些化合物作为PAR4抑制剂的方法，以及包含这些化合物的药物组合物。这些化合物用于抑制或预防血小板聚集，用于治疗血栓栓塞障碍或作为血栓栓塞障碍的初级预防。
• Benzoyl-piperidine derivatives as dual modulators of the 5-HT2A and D3 receptors
  申请人：Gobbi Luca

  公开号：US20070197531A1

  公开（公告）日：2007-08-23

  The present invention relates to compounds of the general formula as dual modulators of the 5-HT 2a and D 3 receptors useful against CNS disorders, wherein A, R 1 , R 2 , n, p, q and r are as defined in the specification.

  本发明涉及一般公式的化合物，作为5-HT2a和D3受体的双重调节剂，用于对抗中枢神经系统疾病，其中A、R1、R2、n、p、q和r的定义如规范中所述。
• [EN] ANDROGEN RECEPTOR ANTAGONISTS AND USES THEREOF<br/>[FR] ANTAGONISTES DES RÉCEPTEURS D'ANDROGÈNES ET LEURS UTILISATIONS
  申请人：SUZHOU KINTOR PHARMACEUTICALS INC

  公开号：WO2012119559A1

  公开（公告）日：2012-09-13

  Disclosed are substituted thioimidazolidinone compounds and pharmaceutical compositions comprising such compounds. The compounds and compositions can be used for treatment of androgen receptor-associated diseases or disorders, such as prostate cancer, benign prostatic hypertrophy, male hair loss and hypertrichosis.

  本申请公开了替代噻嗪唑烷酮化合物和包含这种化合物的药物组合物。这些化合物和组合物可用于治疗与雄激素受体相关的疾病或疾病，如前列腺癌、良性前列腺肥大、男性脱发和多毛症。
• Perkin–Markovnikov Type Reaction Initiated with Electrogenerated Superoxide Ion
  作者：Fumihiro Ojima、Tetsuo Osa

  DOI：10.1246/bcsj.62.3187

  日期：1989.10

  The cyclic condensation of active methylene compounds such as diethyl malonate, dimethyl malonate, ethyl acetoacetate, or acetylacetone and dibromoalkanes such as 1,2-dibromoethane, 1,3-dibromopropane, 1,4-dibromobutane, 1,5-dibromopentane, 1,6-dibromohexane, 1,3-dibromobutane, or 1,4-dibromopentane with electrogenerated superoxide ion was studied electrochemically in N,N-dimethylformamide (DMF) using cyclic voltammetry (CV) and controlled potential macro-electrolysis. The CV shows that electrogenerated superoxide ion reacts with both active methylene compounds and dibromoalkanes in the dissolved oxygen medium. Controlled potential macro-electrolysis of the above components generally yielded cycloalkanes as the main products. In comparison, the chemical method using sodium ethoxide was also carried out. Two reaction mechanisms via the proton abstraction of active methylene compounds with electrogenerated superoxide ion and via the nucleophilic attack of the superoxide ion on dibromoalkanes are presented.

  活性亚甲基化合物，如二乙基马来酸酯、二甲基马来酸酯、乙酰乙酸乙酯或乙酰乙酮，与二溴烷烃，如1,2-二溴乙烷、1,3-二溴丙烷、1,4-二溴丁烷、1,5-二溴戊烷、1,6-二溴己烷、1,3-二溴丁烷或1,4-二溴戊烷的循环缩合反应，采用循环伏安法（CV）和控制电位宏电解法在N,N-二甲基甲酰胺（DMF）中进行了电化学研究。CV结果表明，电生超氧阴离子在溶解氧介质中与活性亚甲基化合物和二溴烷烃均发生反应。上述组分的控制电位宏电解通常以环烷烃作为主要产物。相比之下，使用乙醇钠的化学方法也进行了研究。提出了两种反应机理：一种是活性亚甲基化合物与电生超氧阴离子的质子抽取反应，另一种是超氧阴离子对二溴烷烃的亲核攻击反应。
• CYCLOPROPYLAMINES AS LSD1 INHIBITORS
  申请人：INCYTE CORPORATION

  公开号：US20150225401A1

  公开（公告）日：2015-08-13

  The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.

  本发明涉及环丙胺衍生物，其为LSD1抑制剂，可用于治疗癌症等疾病。